Insight Preparing for disease-modifying therapies in Alzheimer's disease

被引：11
|
作者：
Belder, Christopher R. S.
Schott, Jonathan M.
Fox, Nick C.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 09期
关键词：
D O I：
10.1016/S1474-4422(23)00274-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：782 / 783
页数：2
相关论文
共 50 条
  • [1] The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease
    Ritchie, Craig W.
    Russ, Tom C.
    Banerjee, Sube
    Barber, Bob
    Boaden, Andrew
    Fox, Nick C.
    Holmes, Clive
    Isaacs, Jeremy D.
    Leroi, Ira
    Lovestone, Simon
    Norton, Matt
    O'Brien, John
    Pearson, Jim
    Perry, Richard
    Pickett, James
    Waldman, Adam D.
    Wong, Wai Lup
    Rossor, Martin N.
    Burns, Alistair
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [2] Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease
    Dobson, Ruth
    Patterson, Katherine
    Malik, Reshad
    Mandal, Uttara
    Asif, Hina
    Humphreys, Ros
    Payne, Michael
    O-Charoenrat, Eng
    Huzzey, Lauren
    Clare, Adam
    Green, Kate
    Morton, Maija
    Sohrabi, Catrin
    Singh, Navreen
    Pasupathy, Amirtha
    Patel, Milan
    Whiteman, Sam
    Maxmin, Kate
    Bass, Nicholas
    Gupta, Bhavya
    Cooper, Claudia
    Marshall, Charles
    Weil, Rimona Sharon
    Mummery, Catherine J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (09): : 796 - 803
  • [3] The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
    Craig W. Ritchie
    Tom C. Russ
    Sube Banerjee
    Bob Barber
    Andrew Boaden
    Nick C. Fox
    Clive Holmes
    Jeremy D. Isaacs
    Ira Leroi
    Simon Lovestone
    Matt Norton
    John O’Brien
    Jim Pearson
    Richard Perry
    James Pickett
    Adam D. Waldman
    Wai Lup Wong
    Martin N. Rossor
    Alistair Burns
    [J]. Alzheimer's Research & Therapy, 9
  • [4] Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
    Henrik Zetterberg
    Barbara B. Bendlin
    [J]. Molecular Psychiatry, 2021, 26 : 296 - 308
  • [5] Disease-modifying therapies in Alzheimer's disease
    Salloway, Stephen
    Mintzer, Jacobo
    Weiner, Myron F.
    Cummings, Jeffrey L.
    [J]. ALZHEIMERS & DEMENTIA, 2008, 4 (02) : 65 - 79
  • [6] Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease
    Craig W. Ritchie
    Tom C. Russ
    Sube Banerjee
    Bob Barber
    Andrew Boaden
    Nick C. Fox
    Clive Holmes
    Jeremy D. Isaacs
    Ira Leroi
    Simon Lovestone
    Matt Norton
    John O’Brien
    Jim Pearson
    Richard Perry
    James Pickett
    Adam D. Waldman
    Wai Lup Wong
    Martin N. Rossor
    Alistair Burns
    [J]. Alzheimer's Research & Therapy, 10
  • [7] Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies
    Zetterberg, Henrik
    Bendlin, Barbara B.
    [J]. MOLECULAR PSYCHIATRY, 2021, 26 (01) : 296 - 308
  • [8] Novel Disease-Modifying Therapies for Alzheimer's Disease
    Jiang, Teng
    Yu, Jin-Tai
    Tan, Lan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 475 - 492
  • [9] Disease-modifying therapies for Alzheimer disease
    Cummings, Jeffrey L.
    Doody, Rachelle
    Clark, Christopher
    [J]. NEUROLOGY, 2007, 69 (16) : 1622 - 1634
  • [10] Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease
    Munoz-Torrero, D.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (24) : 2433 - 2455
12345